CABERGOLINE
Active substance: cabergoline
TABLET · CABERGOLINE .5 mg/1
United StatesActive
Marketing holder: Somerset Therapeutics, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- CABERGOLINE · .5 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 14 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-353a-7294-aa5b-450ab75e2e1e,01a120c3-3f80-7acb-b148-7903f45f28ed,01a120c3-3f83-7722-b7f6-f1c9c542d4fb,01a120c3-45d8-7ca9-897d-dfb1431987d8,01a120c3-946f-7ee9-a95f-b33a917be906;count=12 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-8c44-71f2-9842-8aa9ee396b5b,01a1208f-9751-7442-b99e-ecd71d35f887,01a1208f-c73b-7949-abe2-b158fff66493,01a12090-b0c7-7c1d-96cb-8c709fa9e1f3,01a12091-aebb-7e7d-8f51-1b77db9fcf5e;count=12 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 70069-824
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 70069-824 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70069-824 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70069-824 · Verified 2026-10-09 · open in source